Humans live in a 24-hour environment, in which light and darkness follow a diurnal pattern. Our circadian pacemaker, the suprachiasmatic nuclei (SCN) in the hypothalamus, is entrained to the 24-hour solar day via a pathway from the retina and synchronises our internal biological rhythms. Rhythmic variations in ambient illumination impact behaviours such as rest during sleep and activity during wakefulness as well as their underlying biological processes. Rather recently, the availability of artificial light has substantially changed the light environment, especially during evening and night hours. This may increase the risk of developing circadian rhythm sleep–wake disorders (CRSWD), which are often caused by a misalignment of endogenous circadian rhythms and external light–dark cycles. While the exact relationship between the availability of artificial light and CRSWD remains to be established, nocturnal light has been shown to alter circadian rhythms and sleep in humans. On the other hand, light can also be used as an effective and noninvasive therapeutic option with little to no side effects, to improve sleep, mood and general well-being. This article reviews our current state of knowledge regarding the effects of light on circadian rhythms, sleep, and mood.

Ocular light exposure has important influences on human health and well-being through modulation of circadian rhythms and sleep, as well as neuroendocrine and cognitive functions. Prevailing patterns of light exposure do not optimally engage these actions for many individuals, but advances in our understanding of the underpinning mechanisms and emerging lighting technologies now present opportunities to adjust lighting to promote optimal physical and mental health and performance. A newly developed, international standard provides a SI-compliant way of quantifying the influence of light on the intrinsically photosensitive, melanopsin-expressing, retinal neurons that mediate these effects. The present report provides recommendations for lighting, based on an expert scientific consensus and expressed in an easily measured quantity (melanopic equivalent daylight illuminance (melaponic EDI)) defined within this standard. The recommendations are supported by detailed analysis of the sensitivity of human circadian, neuroendocrine, and alerting responses to ocular light and provide a straightforward framework to inform lighting design and practice.

Significance: Our eyes sense bright light using cones (L, M, and S) and recently discovered melanopsin-containing ganglion cells. Both S cones and melanopsin respond to blueish (short-wavelength) light. How does melanopsin interact with the cones in visual function? We measured the response of the human pupil to isolated stimulation of the different photoreceptors. Our work reveals a curious, opponent response to blue light in the otherwise familiar pupillary light response. Increased stimulation of S cones can cause the pupil to dilate, but this effect is usually masked by a stronger and opposite response from melanopsin-containing cells. Our results have clinical importance because the sensing of blue light is known to be related to seasonal depression, sleep, and pain from bright light.

The illumination of the environment undergoes both intensity and spectral changes during the 24 h cycle of a day. Daylight spectral power distributions are well described by low-dimensional models such as the CIE (Commission Internationale de l’Éclairage) daylight model, but the performance of this model in non-daylight regimes is not characterised. We measured downwelling spectral irradiance across multiple days in two locations in North America: One rural location (Cherry Springs State Park, PA) with minimal anthropogenic light sources, and one city location (Philadelphia, PA). We characterise the spectral, intensity and colour changes and extend the existing CIE model for daylight to capture twilight components and the spectrum of the night sky.

Melanopsin is a short-wavelength-sensitive photopigment that was discovered only around 20 years ago. It is expressed in the cell bodies and processes of a subset of retinal ganglion cells in the retina (the intrinsically photosensitive retinal ganglion cells; ipRGCs), thereby allowing them to signal light even in the absence of cone and rod input. Many of the fundamental properties of melanopsin signalling in humans for both visual (e.g. detection, discrimination, brightness estimation) and non-visual function (e.g. melatonin suppression, circadian phase shifting) remain to be elucidated. Here, we give an overview of what we know about melanopsin contributions in visual function and non-visual function.

Exposure to light has short- and long-term impacts on non-visual responses in humans. While many aspects related to non-visual light sensitivity have been characterised (such as the action spectrum for melatonin suppression), much remains to be elucidated. Here, we provide a set of minimum reporting guidelines for reporting the stimulus conditions involving light as an intervention in chronobiology, sleep research and environmental psychology experiments. Corresponding to the current state-of-the-art knowledge (June 2019), these are (i) measure and report the spectral power distribution of the acute stimulus from the observer’s point of view; (ii) measure and report the spectral power distribution of the background light environment from the observer’s point of view; (iii), make spectra available in tabulated form, (iv) report α-opic (ir)radiances and illuminance; (v) describe the timing properties of stimulus (duration and pattern); (vi) describe the spatial properties of stimulus (spatial arrangement and extent), and (vii) report measurement conditions and equipment. We supplement the minimum reporting guidelines with optional reporting suggestions and discuss limitations of the reporting scheme.